Cost-Utility Analysis of Antihemophilic Factor Rfviii-Fs for Secondary Prophylaxis Vs on-Demand Therapy In Severe Haemophilia A In Italy.

Abstract

Sorry, we couldn't extract an abstract for this paper.
DOI: 10.1016/j.jval.2015.09.1974

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.